(1)Kimura H, Nagasawa K, Kimura R, Tsukagoshi H, Matsushima Y, Fujita K, Hirano E, Ishiwada N, Misaki T, Oishi K, Kuroda M, Ryo A. Molecular evolution of the fusion protein (F) gene in human respiratory syncytial virus subgroup B. Infect Genet Evol. 52:1-9, 2017.
(2)Mizukoshi F, Nagasawa K, Doan YH, Haga K, Yoshizumi S, Ueki Y, Shinohara M, Ishikawa M, Sakon N, Shigemoto N, Okamoto-Nakagawa R, Ochi A, Murakami K, Ryo A, Suzuki Y, Katayama K, Kimura H. Molecular evolution of the RNA-dependent RNA polymerase and capsid genes of human norovirus genotype GII.2 in Japan during 2004–2015. Front Microbiol. 8:705, 2017.
(3)Miyakawa K, Nishi M, Matsunaga S, Okayama A, Anraku M, Kudoh A, Hirano H, Kimura H, Morikawa Y, Yamamoto N, Ono A, Ryo A. The tumor suppressor APC promotes HIV-1 assembly via interaction with Gag precursor protein. Nat Commun. 30;8:14259, 2017.
(4)Kobayashi M, Matsushima Y, Motoya T, Sakon N, Shigemoto N, Okamoto-Nakagawa R, Nishimura K, Yamashita Y, Kuroda M, Saruki N, Ryo A, Saraya T, Morita Y, Shirabe K, Ishikawa M, Takahashi T, Shinomiya H, Okabe N, Nagasawa K, Suzuki Y, Katayama K, Kimura H. Molecular evolution of the capsid gene in human norovirus genogroup II. Sci Rep. 6:29400, 2016.
(5)Kimura H, Nagasawa K, Tsukagoshi H, Matsushima Y, FujitaK, Yoshida LY, Tanaka R, Ishii H, Shimojo N, Kuroda M, Ryo A. Molecular evolution of the fusion protein gene in human respiratory syncytial virus subgroup A. Infect Genet Evol. 43:398-406, 2016.
(6)Sugai K, Kimura H, Miyaji Y, Tsukagoshi H, Yoshizumi M, Sasaki-Sakamoto T, Matsunaga S, Yamada Y, Noda M,Ikeda M, Kozawa K, Ryo A, Yoshihara S, Ogata H, Okayama Y. MIP-1a level in nasopharyngeal aspirates at first wheezing episode predicts recurrent wheezing. J Allergy Clin Immunol. 137(3):774-781, 2016.
(7)Kobayashi M, Yoshizumi S, Takahashi T, Ueki Y, Shinohara M, Mizukoshi F, Tsukagoshi H, Sasaki Y, Suzuki R, Shimizu H, Iwakiri A, Okabe N, Shirabe K, Shinomiya H, Kozawa K, Ryo A, Kuroda M, Katayama K, Kimura H, Molecular Evolution of the capsid gene in norovirus genogroup I. Sci Rep. 4;5:13806, 2015.
(8)Kimura H, Saitoh M, Kobayashi M, Ishii H, Saraya T, Kurai D, Tsukagoshi H, Shirabe K, Nishina A, Kozawa K, Kuroda M, Takeuchi F, Sekizuka T, Minakami H, Ryo A, Takeda M. Molecular evolution of haemagglutinin (H) gene in measles virus. Sci Rep. 5:11648, 2015.
(9)Miyakawa K, Matsunaga S, Kanou K, Matsuzawa A, MorishitaR, Kudoh A, Shindo K, Yokoyama M, Sato H, Kimura H, Tamura T, Yamamoto N, Ichijo H, Takaori-Kondo A, Ryo A. ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction. Nat Commun. 6:6945.1.2015.
(10)Kuroda M, Niwa S, Sekizuka T, Tsukagoshi H, Yokoyama M, Ryo A, Sato H, Kiyota N, Noda M, Kozawa K, Shirabe K, Kusaka T, Shimojo N, Hasegawa S, Sugai K, Obuchi M, Tashiro M, Oishi K, Ishii H, Kimura H. Molecular evolution of the VP1, VP2, and VP3 genes in human rhinovirus species C. Sci Rep. 5:8185, 2015.
(11)Hirano E, Kobayashi M, Tsukagoshi H, Yoshida LM, Kuroda M, Noda M, Ishioka T, Kozawa K, Ishii H, Yoshida A, Oishi K, Ryo A, Kimura H, Molecular evolution of human respiratory syncytial virus attachment glycoprotein (G) gene of new genotype ON1 and ancestor NA1. Infect Genet Evol. 28:183-191, 2014.
(12)Nishi M, Akutsu H, Kudoh A, Kimura H, Yamamoto N, Umezawa A, Lee SW, Ryo A. Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell. Oncotarget. 5(18):8665-8680, 2014.
(13)Nishi M, Sakai Y, Akutsu H, Nagashima Y, Quinn G, Masui S, Kimura H, Perrem K, Umezawa A, Yamamoto N,Lee SW, Ryo A. Induction of cells with cancer stem-cell properties from non-tumorigenic human mammary epithelial cells by defined reprogramming factors. Oncogene. 33(5):643-52, 2014.
(14)Kobayashi M, Takayama I, Kageyama T, Tsukagoshi H, Saitoh M, Ishioka T, Yokota Y, Kimura H, Tashiro M, Kozawa K. A new reassortant swine influenza A (H1N2) virus derived from A (H1N1) pdm09 virus isolated from swine. Emerg Infect Dis. 19(12):1972-4, 2013.
(15)Abe M, Tahara M, Yamaguchi H, Kanou K, Shirato K, Kawase M, Noda M, Kimura H, Matsuyama S, Fukuhara H, Mizuta K, Maenaka K, Ami Y, Esumi M, Kato A, Takeda M. TMPRSS2 is an activating protease for respiratory parainfluenza viruses. J Virol. 87(21):11930-11935, 2013.
(16)Sakano C, Kuroda M, Sekizuka T, Ishioka T, Morita Y, Ryo A, Tsukagoshi H, Kawai Y, Inoue N, Takada H, Ogasawara Y, Nishina A, Shimoda M, Kozawa K, Oishi K, Kimura H. Genetic analysis of non-hydrogen sulfide-producing Salmonella enterica serovar Typhimurium and Infantis isolates in Japan. J Clin Microbiol. 51(1):328-330, 2013.
(17)Kobayashi M, Tsukagoshi H, Ishioka T, Mizuta K, Noda M, Morita Y, Ryo A, Kozawa K, Kimura H. Seroepidemiology of saffold cardiovirus (SAFV) genotype 3 in Japan. J Infect. 66(2):191-193, 2013.
(18)Miyakawa K, Sawasaki T, Matsunaga S, Tokarev A, Quinn G, Kimura H, Nomaguchi M, Adachi A, Yamamoto N, Guatelli J, Ryo A. Interferon-Induced SCYL2 Limits Release of HIV-1 by Triggering PP2A-Mediated Dephosphorylation of the Viral Protein Vpu. Sci Signal. 5(245):ra73, 2012.
(19)Fujitsuka A, Tsukagoshi H, Arakawa M, Goto-Sugai K, Ryo A, Okayama Y, Mizuta K, Nishina A, Yoshizumi M, Kaburagi Y, Noda M, Tashiro M, Okabe N, Mori M, Yokota S, Kimura H. A molecular epidemiological study of respiratory viruses detected in Japanese children with acute wheezing illness. BMC Infect Dis. 11:168, 2011.
(20)Mukai H, Seki T, Nakano H, Hokari Y, Takao T, Kawanami M, Tsukagoshi H, Kimura H, Kiso Y, Shimonishi Y, Nishi Y, Munekata E. Mitocryptide-2: Purification, ientification ,and characterization of a novel cryptide that activates neutrophils. J Immunol. 182(8):5072-5080, 2009.
(21)Mukai H, Hokari Y, Seki T, Takao T, Kubota M, Matsuo Y, Tsukagoshi H, Kato M, Kimura H, Shimonishi Y, Kiso Y, Nishi Y, Wakamatsu K, Munekata E. Discovery of mitocryptide-1, a neutrophil-activating cryptide from healthy porcine heart. J Biol Chem. 283(45):30596-30605, 2008.
(22)Okazaki K, Kondo M, Kato M, Kakinuma R, Nishida A, Noda M, Taniguchi K, Kimura H. Serum cytokine and chemokine profiles in neonates with meconium aspiration syndrome. Pediatrics. 121(4):e748-e753, 2008.
(23)Tsukagoshi H, Koketsu M, Kato M, Kurabayashi M, Nishina A, Kimura H. Superoxide radical (O2-) scavenge effects from polymorphonuclear leukocytes and toxicity in human cell lines of newly synthesized organic selenium compounds. FEBS J. 274(23):6046-6054, 2007.
(24)Wada T, Toma T, Okamoto H, Kasahara Y, Koizumi S, Agematsu K, Kimura H, Shimada A, Hayashi Y, Kato M, Yachie Y. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood. 106(6):2099-2101, 2005.
(25)Nishida T, Kimura H, Saitoh M, Shinohara M, Kato M, Fukuda S, Munemura T, Mikami T, Kawamoto A, Akiyama M, Kato Y, Nishi K, Kozawa K, Nishio O. Detection, quantitation, and phylogenetic analysis of noroviruses in Japanese oysters. Appl Environ Microbiol. 69(10):5782-5786, 2003.
(26)Kimura H, Saitoh M, Miyakubo H, Yoshida H, Kato K, Nagai A, Kozawa K. Keratoconjunctivitis caused by echovirus type 13 in Japanese children. Pediatr Infect Dis J. 22(8):758-759, 2003.
(27)Kato M, Suzuki M, Tachibana A, Takizawa T, Arkawa H, Mochizuki H, Tokuyama K, Kimura H, Hanaka H, Izumi T, Morikawa A. Actin assembly is a crucial role on effector functions of adherent human eosinophils. J Allegy Clin Immunol. 111(1): 126-33, 2003.
(28)Kato M, Kimura H, Motegi Y, Tachibana A, Minakami H, Morikawa A, Kita H. Platelet-activating factor activates two distinct signaling and effector pathways in human eosinophils. J Immunol. 169(9):5252-5259, 2002.
(29)Takizawa T, Kato M, Kimura H, Tachibana A, Fujiu T, Suzuki M, Tokuyama K, Morikawa A. Inhibition of protein kinase A and C exhibits dual modes of responses in human eosinophils stimulated by platelet-activating factor. J Allergy Clin Immunol. 110:241-248, 2002.
(30)Okada Y, Kato M, Minakami H, Inoue Y, Morikawa A, Otsuki K, Kimura H. Reduced expression of FLICE-inhibitory protein (FLIP) and NFkB1 is associated with death receptor-induced cell death in human aortic endothelial cells (HAECs). Cytokine. 15(2):66-74, 2001.
(31)Kimura H, Minakami H, Harigaya A, Takeuchi H, Tachibana A, Otsuki K. Treatment of neonatal infection caused by coxsackievirus B3. J Perinatol. 19(5):388-390, 1999.
(32)Kimura H, Minakami H, Kimura S, Sakurai T, Nakamura T, Kurashige S, Nakano M, Shoji A. Release of superoxide radicals by mouse macrophages stimulated by oxidative modification of glycated low density lipoproteins. Atherosclerosis 118:1-8, 1995.
(33)Sakurai T, Kimura S, Nakano M, and Kimura H. The oxidative modification of low density lipoprotein by nonenzymatically glycated peptide-Fe complex. Biochim Biophys Acta. 1086:273-278, 1991.
(34)Nakano M, Kimura H, Hara M, Kuroiwa M, Kato M, Totsune K, Yoshikawa T. A highly sensitive method for determining both Mn- and Cu-Zn superoxide dismutase activities in tissues and blood cells. Anal Biochem. 187:277-280, 1990.
(35)Kimura H, Nakano M. Highly sensitive and reliable chemiluminescence method for the assay of superoxide dismutase in human erythrocytes. FEBS Lett. 239(2):347- 350, 1988.